5.660SEK+1.07%Mkt Cap: 17.60M $P/E: —1d ago
SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also …
Indicators:|
Key Statistics
Company
Market Cap17.60M $
Enterprise Value15.66M $
Revenue (TTM)5.67M $
Gross Profit3.59M $
Net Income (TTM)-1.11M $
Revenue/Share0.1874 USD
Last Price5.660 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees33
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-56.60
PEG—
EV/EBITDA-37.56
EV/Revenue2.76
P/S3.10
P/B2.01
EPS (TTM)-0.36
EPS (Forward)-0.10
52W Range
4.60047% of range6.840
52W High6.840 SEK
52W Low4.600 SEK
Profitability
Gross Margin64.80%
Oper. Margin-14.20%
EBITDA Margin-7.35%
Profit Margin-19.99%
ROE-14.91%
ROA-9.98%
Growth
Revenue Growth9.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-652.63K $
CapEx (TTM)524.84K $
FCF Margin-19.47%
FCF Yield-6.27%
Net Debt-1.94M $
Net Debt/EBITDA4.65
Balance Sheet
Debt/Equity0.24
Current Ratio2.95
Quick Ratio2.64
Book Value/Sh2.821 SEK
Cash/Share1.171 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.32.51M
Float24.40M
Insiders24.90%
Institutions12.11%
Technical
SMA 505.467 (+3.5%)
SMA 2005.726 (-1.2%)
Beta0.53
S&P 52W Chg20.05%
Avg Vol (30d)15.82K
Avg Vol (10d)7.76K
Technical Indicators
RSI (14)56.6
MACD0.0332
MACD Signal0.0336
MACD Hist.-0.0004
BB Upper5.812 SEK
BB Middle5.523 SEK
BB Lower5.234 SEK
BB Width10.48%
ATR (14)0.2658 SEK
Vol Ratio (20d)0.94x